Impact of Perinatal Exposure to SARS-CoV-2 Infection on Early Health Outcomes among Infants Born from 2020 to 2021 in British Columbia, Canada
Table 2
Healthcare resource utilization and reason for emergency department visit or hospitalization in the first 12 months after birth among infants with and without perinatal exposure to SARS-CoV-2.
Infants in exposed cohort (n = 480)
Infants in non‐exposedcohort (n = 1904)
Odds ratio (95% CI)†
≥1 emergency department visit
81 (16.88%)
246 (12.92%)
1.40 (1.05, 1.85)
Nausea and/or vomiting
13 (2.71%)
32 (1.68%)
Feeding difficulties in newborn
9 (1.88%)
16 (0.84%)
Fever
9 (1.88%)
33 (1.73%)
Rash
8 (1.67%)
10 (0.53%)
Inconsolable crying
7 (1.46%)
24 (1.26%)
Shortness of breath
7 (1.46%)
24 (1.26%)
Neonatal jaundice
6 (1.25%)
29 (1.52%)
≥1 hospitalization
39 (8.13%)
98 (5.15%)
1.63 (1.11, 2.41)
Neonatal jaundice
9 (1.89%)
29 (1.52%)
Transient tachypnoea of the newborn
<5
5 (0.26%)
Urinary tract infection
<5
<5
COVID-19
<5
<5
n values < 5 not reported. †The effect estimate for all outcomes was obtained by comparing exposed vs. non‐exposed cohorts. Significant odds ratio (i.e., does not cross 1.0 in 95% CI).
